2020
DOI: 10.1158/1538-7755.disp18-b020
|View full text |Cite
|
Sign up to set email alerts
|

Abstract B020: Antiproliferative efficacy of different targeted drugs on breast cancer cell lines of distinct subtypes

Abstract: Background: Breast cancer is the most common cancer overall, with an estimated 2.4 million incident cases in 2015. Current treatment of breast cancer is mainly surgery, chemotherapy, radiotherapy, and hormonal therapy. Although these approaches appear to be effective, they have failed to result in long-term cure, especially for aggressive HER2-positive and triple-negative breast cancer. This particularly holds for sub-Saharan Africa with a dominance of aggressive breast cancer subtypes with very limited treatm… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles